Principles And The Way Forward
The 67th World Health Assembly in 2014 promoted systematic utilization of independent health intervention and technology assessment in support of universal health coverage to inform policy decisions. To reach this goal, integration between institutional levels and research is needed without geographical or decision-making authority constraint along with a more dynamic collaborative environment. This plenary takes us on an HTA journey across regional networks around the world, describing the interactions between macro, meso and micro decision-making levels. We simplify decision-making interactions and explore whether horizontal and vertical integrations are feasible. We welcome Dr. Wim Goettsch, Director EUnetHTA JA3 Directorate, followed by a panel of experts representing regional networks in Europe, Asia and Latin America. The discussions will be challenged by representatives of hospital and clinical guidelines networks to assess the vertical impact of HTA on hospitals and clinicians, as well as to discuss whether this impact can be enhanced by guidelines and hospital-based HTA on meso and micro levels.
Engaging Professionals And Mastering Big Data For Effective HTA
Health Care systems are more and more engaged in maximizing value from relevant resources invested for health. HTA is key for the implementation of a value-based paradigm. But effective HTA needs the enhancement of both horizontal collaboration (among HTA doers at the same institutional level) and vertical cooperation (among doers at micro, meso and macro levels). HTA production should benefit from both experimental data and real world data produced at any level of the ecosystem and in any moment of the technology’s life cycle. The exploitation of this huge asset needs the development of new professional competencies and new technical capabilities to master big data and to interpret results wisely. This plenary focuses on the contribution of the HTA ecosystem in the implementation of value-based healthcare systems. Speakers are engaged in defining the role of HTA in this paradigm, the challenges in engaging professionals in HTA and the potential contributions that big data analysis could provide in the HTA process.
Prof. Americo Cicchetti, Professor of Management, Faculty of Economics, Catholic University of the Sacred Heart, ItalyDr. Wija Oortwijn, Manager Health Unit, Ecorys Nederland B.V., The Netherlands
SpeakersProf. Gualtiero Ricciardi, President, Istituto Superiore di Sanità, ItalyProf. Christopher Chute, Bloomberg Distinguished Professor, Department of Health Policy and Management, The Johns Hopkins Institute for Clinical and Translational Research, USADr. Merran Smith, Chief Executive, Population Health Research Network, AustraliaDr. Michael Seewald, VP & Worldwide Head, Center of Excellence for Real World Evidence, Novartis Pharma, Switzerland
The Role Of Multi-stakeholder Involvement In HTA
An HTA-ecosystem hosts a variety of mutually dependent agents and agencies who function in ways that give rise to the emergence of system properties such as equity and sustainability. It is based on mutual recognition and a sufficient degree of agreement on what a properly functioning health care system looks like and how it can best be achieved. Clearly, an HTA-ecosystem entails different roles for the various stakeholders and for how they should collaborate. In this session, Norman Daniels, Mary B. Saltonstall Professor of Population Ethics and Professor of Ethics and Population Health in the Department of Global Health and Population at the Harvard School of Public Health will argue that accountability for reasonableness could be an appropriate framework for stakeholder involvement and deliberation in HTA. A panel discussion will address the question of how this might be incorporated in the current practice of HTA.
Co-chairsEleanor Bradford, Head of Communications, University of Aberdeen, UKDr. Sean Tunis, Founder & Chief Executive Officer, Center for Medical Technology Policy (CMTP), USA
Prof. Norman Daniels, Mary B. Saltonstall Professor of Population Ethics and Professor of Ethics and Population HealthDepartment of Global Health and Population, Harvard School of Public Health, USA
Prof. Antonio Gasbarrini, Director of Internal Medicine, Fondazione Policlinico "A. Gemelli", ItalyJolanta Bilinska, Chair, International Alliance of Patients' Organizations, PolandAlexandre Lemgruber, Regional Advisor - Health Technologies, PAHO - Pan American Health Organization, Brazil